Location History:
- Habana, CU (2002)
- Havana, CU (2002)
Company Filing History:
1 out of 2 
1 out of 15 Years Active: 2002
Title: **Innovative Contributions of Dagmara Pichardo Diaz in Vaccine Development**
Introduction: Dagmara Pichardo Diaz is an accomplished inventor based in Habana, Cuba, recognized for her significant contributions to the field of medicine, particularly in vaccine development. With a focus on enhancing immune response, her work embodies the spirit of innovation that propels advancements in healthcare.
Latest Patents: Dagmara holds two notable patents that showcase her inventive prowess. The first patent is titled "Formulation of nucleic acid and acemannan," which describes a formulation comprising a nucleic acid vaccine combined with an immunoenhancing amount of acemannan. This invention aims to enhance the immune response in a host when administered with the vaccine. The second patent focuses on "Immunopotentiating formulations for vaccinal use," where she developed new adjuvant formulations with vaccine antigens. This invention seeks to modulate the immune response of the organism to these vaccine antigens effectively.
Career Highlights: Dagmara's career includes impactful work at renowned institutions such as the Centro de Ingeniería Genética y Biotecnología, where she has collaborated with fellow researchers to advance medical science. Her focus on developing formulations that can be utilized in both human and veterinary vaccines highlights her commitment to improving public health through scientific innovation.
Collaborations: Throughout her career, Dagmara Pichardo Diaz has collaborated with several key individuals, including Julio Cesar Aguilar Rubido and Verena Lucila Muzio Gonzalez. These partnerships have fostered a collaborative environment that thrives on research and development, leading to groundbreaking advancements in vaccine technology.
Conclusion: Dagmara Pichardo Diaz's contributions to the field of immunology demonstrate the critical role of innovation in developing effective vaccines. Her patents reflect a deep understanding of the challenges in vaccine technology and a commitment to advancing health solutions. As she continues her work, Dagmara stands as a testament to how dedicated inventors can impact the future of medicine through creativity and scientific inquiry.